Xponance’s Claritev Corp CTEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-566
Closed -$18.4K 1373
2024
Q1
$18.4K Sell
566
-9
-2% -$379 ﹤0.01% 1297
2023
Q4
$33.1K Buy
575
+20
+4% +$1.21K ﹤0.01% 1255
2023
Q3
$37.3K Hold
555
﹤0.01% 1219
2023
Q2
$46.8K Buy
555
+17
+3% +$908 ﹤0.01% 1231
2023
Q1
$22.8K Hold
538
﹤0.01% 1211
2022
Q4
$24.8K Buy
538
+8
+2% +$639 ﹤0.01% 1209
2022
Q3
$61K Buy
530
+20
+4% +$3.31K ﹤0.01% 1140
2022
Q2
$112K Buy
510
+123
+32% +$24.3K ﹤0.01% 1123
2022
Q1
$73K Sell
387
-64
-14% -$10.5K ﹤0.01% 1137
2021
Q4
$80K Buy
451
+184
+69% +$32.8K ﹤0.01% 1144
2021
Q3
$60K Sell
267
-279
-51% -$75.5K ﹤0.01% 1151
2021
Q2
$208K Buy
+546
New +$169K ﹤0.01% 1177

Other funds holding CTEV

Xponance's CTEV Position: Q2 2024 in Review

Xponance sold out of Claritev Corp (CTEV) in Q2 2024, closing a stake of 566 shares — an estimated $18.4K sold.

Xponance first reported a position in CTEV in Q2 2021 and held it in 12 quarters. The position peaked at $208K in Q2 2021. 109 funds tracked by Wall St. Rank hold CTEV as of Q2 2024.

  • Xponance reported no remaining Claritev Corp position as of Q2 2024 after selling out during the quarter.
  • Xponance sold 566 Claritev Corp shares in Q2 2024, an estimated $18.4K.
  • Xponance first reported a position in Claritev Corp in Q2 2021 and held it in 12 quarters.
  • Xponance's Claritev Corp position peaked at $208K in Q2 2021.
  • 109 funds tracked by Wall St. Rank held Claritev Corp as of Q2 2024.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.